News | May 11, 2024
Neuland Laboratories posts Q4 FY24 consolidated PAT at Rs. 67.56 Cr
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
Cipla has received 8 inspectional observations in Form 483
He brings over 30 years of experience across various organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others
Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
The study also showed a clear dose-dependent trend, with the 75 mg QD group outperforming the 50 mg QD cohort
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
The submission is supported by results from the Phase 3b APEX study
Subscribe To Our Newsletter & Stay Updated
